Patient Specific Virtual Reality for Simulation of Spine Procedures: an Intelligent Image Segmentation, Registration and 3-dimensional Visualization in a Unified Virtual Reality Workflow for Image Guided Therapy, and Education - Physician Testing
Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · Nov 28, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of virtual reality (VR) simulations to help train doctors in spine surgery. The researchers want to see if these patient-specific VR experiences can improve the education of resident and fellow physicians who are learning about spine procedures. By using advanced technology to create 3D models based on actual patients, the hope is that doctors in training can practice and understand surgeries better before performing them on real patients.
If you are a resident or a fellow physician enrolled in a spine surgery training program at a participating site, you may be eligible to take part in this study. There are no specific exclusions, which means most residents and fellows in this field can join. Participants can expect to engage with cutting-edge VR technology, providing a unique opportunity to enhance their surgical skills in a safe and controlled environment. This trial is not yet recruiting, but it represents an exciting step forward in medical education.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any resident of fellow physician enrolled in the participating site's spine surgery training program.
- Exclusion Criteria:
- • None.
About Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre is a leading academic health science organization located in Toronto, Canada, renowned for its commitment to advancing patient care through innovative research and education. As a prominent clinical trial sponsor, Sunnybrook integrates cutting-edge medical research with clinical practice, focusing on a wide range of health disciplines, including cancer care, trauma, and cardiovascular health. The center collaborates with various stakeholders, including academic institutions, healthcare providers, and industry partners, to facilitate the development of novel therapies and improve health outcomes. With a robust infrastructure and a dedicated team of researchers and clinicians, Sunnybrook plays a pivotal role in translating scientific advancements into tangible benefits for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dr. Michael Hardisty
Principal Investigator
Sunnybrook Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported